These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 8104112)
21. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice. Otaegui D; Rodríguez-Gascón A; Zubia A; Cossío FP; Pedraz JL Cancer Chemother Pharmacol; 2009 Jun; 64(1):153-9. PubMed ID: 19002463 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314 [TBL] [Abstract][Full Text] [Related]
25. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. Cossum PA; Truong L; Owens SR; Markham PM; Shea JP; Crooke ST J Pharmacol Exp Ther; 1994 Apr; 269(1):89-94. PubMed ID: 8169856 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice. Chaves JS; Leal PC; Pianowisky L; Calixto JB Planta Med; 2008 Nov; 74(14):1678-83. PubMed ID: 18951339 [TBL] [Abstract][Full Text] [Related]
28. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine. Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration. Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration. Goudah A; Abo El Sooud K; Abd El-Aty AM Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602 [TBL] [Abstract][Full Text] [Related]
31. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
32. In vivo pharmacokinetics and metabolism of anti-human immunodeficiency virus agent D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] (SAMPIDINE) in mice. Chen CL; Venkatachalam TK; Zhu ZH; Uckun FM Drug Metab Dispos; 2001 Jul; 29(7):1035-41. PubMed ID: 11408371 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Schluep T; Cheng J; Khin KT; Davis ME Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and tissue distribution of a DNA-methyltransferase antisense (MT-AS) oligonucleotide and its catabolites in tumor-bearing nude mice. Qian M; Chen SH; von Hofe E; Gallo JM J Pharmacol Exp Ther; 1997 Aug; 282(2):663-70. PubMed ID: 9262328 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904 [TBL] [Abstract][Full Text] [Related]
36. In vivo disposition and stability of DNA frayed wires in mice. Yanze MF; Ho EA; Macgregor RB; Piquette-Miller M Int J Biol Macromol; 2006 Nov; 39(4-5):310-6. PubMed ID: 16777215 [TBL] [Abstract][Full Text] [Related]
37. Analytical determination and pharmacokinetics of robenacoxib in the dog. Jung M; Lees P; Seewald W; King JN J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454 [TBL] [Abstract][Full Text] [Related]
38. Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Jiang SZ; Wang NS; Mi SQ Biopharm Drug Dispos; 2008 Dec; 29(9):529-37. PubMed ID: 19051331 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of novel inhibitors of androgen synthesis after intravenous administration in mice. Nnane IP; Njar VC; Brodie AM Cancer Chemother Pharmacol; 2003 Jun; 51(6):519-24. PubMed ID: 12715204 [TBL] [Abstract][Full Text] [Related]